Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma

被引：32
作者：
Belani, CP [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15232 USA
来源：
SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 06期
关键词：
D O I：
10.1053/j.seminoncol.2004.11.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 33
页数：9
相关论文
共 95 条
[1]  
Akerley WL, 2004, J CLIN ONCOL, V22, p666S
[2]  
[Anonymous], P AM SOC CLIN ONCOL
[3]  
[Anonymous], CANC FACTS FIG 2004
[4]  
[Anonymous], P ASCO
[5]  
[Anonymous], P AM SOC CLIN ONCOL
[6]  
ARAVANTINOS G, 1997, P AN M AM SOC CLIN, V16, pA159
[7]   Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial [J].
Bajorin, DF ;
McCaffrey, JA ;
Hilton, S ;
Mazumdar, M ;
Kelly, WK ;
Scher, HI ;
Spicer, J ;
Herr, H ;
Higgins, G .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2722-2727
[8]   ETOPOSIDE, DEXAMETHASONE, CYTARABINE, AND CISPLATIN IN VINCRISTINE, DOXORUBICIN, AND DEXAMETHASONE-REFRACTORY MYELOMA [J].
BARLOGIE, B ;
VELASQUEZ, WS ;
ALEXANIAN, R ;
CABANILLAS, F .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1514-1517
[9]   Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation [J].
Belani, CP ;
Barstis, J ;
Perry, MC ;
La Rocca, RV ;
Nattam, SR ;
Rinaldi, D ;
Clark, R ;
Mills, GM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2933-2939
[10]  
BELANI CP, 2001, P AN M AM SOC CLIN, V20, pA323
12345678910